- Additional Information
- Reviews (0)
Dravix 250mg Injection
Dravix 250mg Injection (Tranexamic acid) is an antifibrinolytic agent that completely inhibits the breakdown of fibrin clots. Chemically, Dravix 250mg Injection is trans-4-(Aminomethyl)cyclohexanecarboxylic acid.Dravix 250mg Injection molecular formula is C8H15NO.QUALITATIVE & QUANTITATIVE COMPOSITION Dravix 250mg Injection (Tranexamic acid) is available for administration as: Dravix 250mg InjectionEach capsule contains: Tranexamic acid BP… 250mg Dravix 250mg Injection Each capsule contains: Tranexamic acid BP… 250mg DRAVIX Injection 250mg/5mL Each 5mL contains: Tranexamic acid BP… Dravix 250mg Injection Each 5mL contains: Tranexamic acid BP… 250mg
is used for the treatment of heavy bleeding that occurs during menstrual cycles.
- Short-term management of hemorrhage
is used for short term management of internal bleeding in patients who have hemophilia.
- Hereditary angioedema
is also sometimes used for the prevention of episodes of edema in patients suffering from this rare genetic disorder.
This medicine may be used to stop or reduce the bleeding associated with epistaxis (nose bleeds).
Major & minor side effects for Dravix 250mg Injection
- Sinusitis like symptoms
- Back pain
- Pale skin
- Allergic Skin Reaction severe
- Muscle or joint pain
- Unusual tiredness and weakness
- Change in color vision severe
- Difficulty in breathing severe
- Swelling of face, lips, eyelids, tongue, hands and feet severe
- Pain in the chest region severe
- Dizziness and fainting severe
- Presence of blood in cough severe
When not to use
Dravix 250mg Injection is not recommended for use in patients who have a known history of allergy to Dravix capsule 500 mg 20’s or any other ingredient present in the dosage form. This medicine is not recommended for use in people having a defective color vision as it could make toxicity determination very difficult. This medicine is not recommended for use in people who have hemorrhage in the area between the brain and its outer covering. Obstructive blood clotting disorder